融捷健康
(300247)
| 流通市值：37.34亿 | | | 总市值：37.39亿 |
| 流通股本：8.03亿 | | | 总股本：8.04亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 239,862,774.58 | 933,150,483.42 | 651,895,498.63 | 432,764,125.61 |
| 营业收入 | 239,862,774.58 | 933,150,483.42 | 651,895,498.63 | 432,764,125.61 |
| 二、营业总成本 | 193,769,700.01 | 785,062,079.82 | 537,277,453.11 | 358,398,007.27 |
| 营业成本 | 154,434,386.9 | 595,735,001.98 | 412,236,665.37 | 277,773,111.91 |
| 税金及附加 | 2,545,135.23 | 6,336,336.95 | 5,012,681.7 | 3,578,180.45 |
| 销售费用 | 18,507,847.68 | 91,460,616.1 | 55,458,260.73 | 36,747,030.15 |
| 管理费用 | 14,211,039.72 | 84,612,924.27 | 63,448,211.78 | 40,054,899.96 |
| 研发费用 | 2,998,149.02 | 12,272,809.19 | 8,858,372.73 | 5,953,591.68 |
| 财务费用 | 1,073,141.46 | -5,355,608.67 | -7,736,739.2 | -5,708,806.88 |
| 其中:利息收入 | - | 13,054,251.52 | - | 6,041,255.9 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,651,224.81 | 514,727.39 | 3,473,019.77 | 5,078,785.47 |
| 加:投资收益 | 99,977.43 | 1,384,477.15 | 378,840.39 | 421,795.82 |
| 资产处置收益 | 7,169.12 | -104,472.64 | -102,561.82 | -4,931.83 |
| 资产减值损失(新) | - | -5,091,908.77 | 138,212.99 | 151,600.05 |
| 信用减值损失(新) | 1,825,369.15 | -972,720.63 | -732,168.43 | 1,239,226.32 |
| 其他收益 | 105,661.22 | 1,575,820.99 | 1,245,404.82 | 848,066.09 |
| 四、营业利润 | 49,782,476.3 | 145,394,327.09 | 119,018,793.24 | 82,100,660.26 |
| 加:营业外收入 | 194,621.53 | 2,740,027.81 | 1,037,768.6 | 1,028,963.58 |
| 减:营业外支出 | 1,700.31 | 202,191.56 | 77,873.34 | 35,732.91 |
| 五、利润总额 | 49,975,397.52 | 147,932,163.34 | 119,978,688.5 | 83,093,890.93 |
| 减:所得税费用 | 13,544,679.55 | 39,787,068.59 | 28,484,525.36 | 18,932,203.03 |
| 六、净利润 | 36,430,717.97 | 108,145,094.75 | 91,494,163.14 | 64,161,687.9 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 36,430,717.97 | 108,145,094.75 | 91,494,163.14 | 64,161,687.9 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 23,735,224.86 | 74,803,222.53 | 66,530,456.08 | 47,523,740.22 |
| 少数股东损益 | 12,695,493.11 | 33,341,872.22 | 24,963,707.06 | 16,637,947.68 |
| 扣除非经常损益后的净利润 | 21,734,249.27 | 68,666,377.33 | 59,467,391.48 | 39,075,334.93 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.03 | 0.09 | 0.08 | 0.06 |
| (二)稀释每股收益 | 0.03 | 0.09 | 0.08 | 0.06 |
| 八、其他综合收益 | -5,105,313.61 | -3,565,380.06 | -3,779,607.86 | -1,373,652.2 |
| 归属于母公司股东的其他综合收益 | -3,318,453.85 | -2,317,497.04 | -2,456,745.11 | -892,873.93 |
| 九、综合收益总额 | 31,325,404.36 | 104,579,714.69 | 87,714,555.28 | 62,788,035.7 |
| 归属于母公司股东的综合收益总额 | 20,416,771.01 | 72,485,725.49 | 64,073,710.97 | 46,630,866.29 |
| 归属于少数股东的综合收益总额 | 10,908,633.35 | 32,093,989.2 | 23,640,844.31 | 16,157,169.41 |
| 公告日期 | 2026-04-28 | 2026-04-22 | 2025-10-27 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |